Eli Lilly’s Sales Slash… And How To Position Ahead Of Bank Results 1/14/25
CNBC's "Fast Money"
00:00
Eli Lilly's Market Dynamics and Stock Performance
This chapter discusses Eli Lilly's recent challenges related to quarterly earnings and the demand for obesity drugs amid supply chain issues. It analyzes insights from company leadership and experts on stock performance, regulatory scrutiny, and investment strategies in response to market fluctuations. The conversation also touches on broader market trends, drawing comparisons with AI stocks and their potential volatility.
Play episode from 01:42
Transcript
